Comparing Three Different Doses of Intrathecal Ketamine
NCT05074823
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
105
Enrollment
OTHER
Sponsor class
Conditions
Ketamine Causing Adverse Effects in Therapeutic Use
Interventions
DRUG:
Ketamine 0.1 mg
DRUG:
Ketamine 0.2 mg
DRUG:
Ketamine 0.3 mg
Sponsor
Assiut University